Clinical Trial Update: Triplet Combination of Cytotoxics as First-line Treatment for Metastatic Gastric Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating a triplet cytotoxic combination as first-line therapy for metastatic gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Metastatic Gastric Cancer | Phase 3 | Status: UNKNOWN